HIGHLIGHTS
- who: March and colleagues from the Uppsala University, Sweden Soochow University, China have published the Article: Cationic lipid-assisted nanoparticles for simultaneous delivery of CD47 siRNA and R848 to promote antitumor immune responses, in the Journal: (JOURNAL)
- what: The authors show that PEG-PLGA nanoparticles are effective nanocarriers that can safely and effectively deliver siCD47 and R848 to tumor tissue, as demonstrated by retarded tumor growth. As far as the authors are concerned, the study reports, for the first time, the combination of siCD47 with R848 for TNBC treatment. The study demonstrated that these NPs . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.